Loading...
Lotus International — Ertapenem Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #11 for Ertapenem · $150.0K export value · DGFT Verified
Lotus International is the #11 Indian exporter of Ertapenem with $150.0K in export value and 3 verified shipments. Lotus International holds a 0.1% market share in Ertapenem exports across 1 countries. The company exports 9 pharmaceutical products worth $1.6M across 7 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $18.4M | 368 | 53.0% |
| MALTA | $6.3M | 126 | 18.2% |
| CANADA | $2.4M | 47 | 6.8% |
| BRAZIL | $1.6M | 32 | 4.6% |
| RUSSIA | $850.0K | 17 | 2.4% |
| SOUTH AFRICA | $850.0K | 17 | 2.4% |
| BELGIUM | $800.0K | 16 | 2.3% |
| UNITED KINGDOM | $750.0K | 15 | 2.2% |
| PERU | $650.0K | 13 | 1.9% |
| COSTA RICA | $600.0K | 12 | 1.7% |
India exports Ertapenem to 46 countries. The top destination is UNITED STATES (53.0%), followed by MALTA and CANADA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EUGIA US LLC, | UNITED STATES | $5.6M | 112 |
| EUGIA US LLC | UNITED STATES | $5.5M | 111 |
| AUROMEDICS PHARMA, LLC, | UNITED STATES | $2.5M | 50 |
| EUGIA PHARMA (MALTA) LTD, | MALTA | $2.0M | 41 |
| EUGIA US LLC. | UNITED STATES | $1.3M | 25 |
India exported $35.1M worth of Ertapenem through 780 shipments from 54 suppliers to 46 countries, serving 137 buyers globally. Lotus International contributes $150.0K to this total, accounting for 0.1% of India's Ertapenem exports.
Lotus International's average Ertapenem shipment value is $50.0K per consignment, based on 3 shipments totaling $150.0K.
Lotus International ranks #11 among 54 Indian Ertapenem exporters with a 0.1% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($26.9M), DR.REDDY'S LABORATORIES LTD ($1.8M), GLAND PHARMA LIMITED ($1.4M). Lotus International processed 3 shipments to 1 destination countries.
What Lotus International must comply with to export Ertapenem to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | SRS PHARMACEUTICALS PRIVATE LIMITED | $200.0K | 4 | 1 | $50.0K |
| 12 | MEDIOR HEALTHCARE PRIVATE LIMITED | $200.0K | 4 | 1 | $50.0K |
| 11 | LOTUS INTERNATIONAL ★ | $150.0K | 3 | 1 | $50.0K |
Lotus International ranks #11 among 54 Indian Ertapenem exporters. Average shipment value of $50.0K compared to the market average of $649.6K. The closest competitors by value are SRS PHARMACEUTICALS PRIVATE LIMITED and MEDIOR HEALTHCARE PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 248 | 31.8% |
| DELHI AIR | 185 | 23.7% |
| Delhi Air | 71 | 9.1% |
| HYDERABAD ACC (INHYD4) | 52 | 6.7% |
| HYDERABAD AIR | 33 | 4.2% |
| PETRAPOLE | 23 | 2.9% |
| SAHAR AIR | 21 | 2.7% |
| Dadri CGML | 19 | 2.4% |
Lotus International exports 9 products worth $1.6M. Beyond Ertapenem, top products include Extract, Semaglutide, Empagliflozin, Torsemide, Canagliflozin. View the complete Lotus International profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ertapenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lotus International's Ertapenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lotus International
Full Company Profile →
9 products · $1.6M total trade · 7 categories
| APL SWIFT SERVICES (MALTA) LTD. | MALTA | $1.3M | 25 |
| EUGIA PHARMA INDUSTRIA FARMACEUTICA | BRAZIL | $1.1M | 21 |
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $850.0K | 17 |
| NORTHSTAR DISTRIBUTION CENTRE 8912 | UNITED STATES | $700.0K | 14 |
| OOOJODAS EXPOIM | RUSSIA | $650.0K | 13 |
India's Ertapenem is purchased by 137 buyers worldwide. The top buyer is EUGIA US LLC, (UNITED STATES), followed by EUGIA US LLC and AUROMEDICS PHARMA, LLC,.
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 137+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Lotus International.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ertapenem. For current shipment-level data, contact TransData Nexus.